This episode focuses on how AI is transforming pharmacovigilance (PV) on a global scale, particularly focusing on the evolving role of local qualified persons for pharmacovigilance in the EU. This episode is presented in partnership with <a href="https://www.iqvia.com/" target="_blank" rel="ugc noopener noreferrer">IQVIA</a>. Host<a href="https://www.linkedin.com/in/lorielliskatz/" target="_blank" rel="ugc noopener noreferrer">⁠⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠⁠</a>, Head of Insights, BioSpace Guest<li><a href="https://www.linkedin.com/in/anapedrojesuino/" rel="ugc noopener noreferrer" target="_blank">Ana Pedro Jesuíno</a>, Global Head Local QPPV Network, IQVIA</li> Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Why Countries Are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.